CIBC Private Wealth Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-600
Closed -$49K 1331
2022
Q1
$49K Buy
+600
New +$50.8K ﹤0.01% 1041
2021
Q4
Sell
-18,769
Closed -$1.64M 1057
2021
Q3
$1.64M Buy
+18,769
New +$1.7M ﹤0.01% 534
2018
Q1
Sell
-207
Closed -$9K 2107
2017
Q4
$9K Buy
+207
New +$9.67K ﹤0.01% 1586

Other funds holding SYNH

CIBC Private Wealth Group's SYNH Position: Q2 2022 in Review

CIBC Private Wealth Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 600 shares — an estimated $49K sold.

CIBC Private Wealth Group first reported a position in SYNH in Q4 2017 and held it in 3 quarters. The position peaked at $1.64M in Q3 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

  • CIBC Private Wealth Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 600 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $49K.
  • CIBC Private Wealth Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Syneos Health, Inc. Class A Common Stock position peaked at $1.64M in Q3 2021.
  • 362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on CIBC Private Wealth Group's 13F filing for Q2 2022, filed 3 Aug 2022.